GB9826392D0 - Pharmaceutical formulations - Google Patents

Pharmaceutical formulations

Info

Publication number
GB9826392D0
GB9826392D0 GBGB9826392.4A GB9826392A GB9826392D0 GB 9826392 D0 GB9826392 D0 GB 9826392D0 GB 9826392 A GB9826392 A GB 9826392A GB 9826392 D0 GB9826392 D0 GB 9826392D0
Authority
GB
United Kingdom
Prior art keywords
pharmaceutical formulations
formulations
pharmaceutical
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB9826392.4A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pfizer Ltd
Original Assignee
Pfizer Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Ltd filed Critical Pfizer Ltd
Priority to GBGB9826392.4A priority Critical patent/GB9826392D0/en
Publication of GB9826392D0 publication Critical patent/GB9826392D0/en
Priority to UA2001042718A priority patent/UA67802C2/en
Priority to TW088116973A priority patent/TW577756B/en
Priority to HU0104318A priority patent/HUP0104318A3/en
Priority to BR9914718-1A priority patent/BR9914718A/en
Priority to CZ20011427A priority patent/CZ20011427A3/en
Priority to JP2000577993A priority patent/JP2002528408A/en
Priority to EEP200100235A priority patent/EE200100235A/en
Priority to MXPA01004011A priority patent/MXPA01004011A/en
Priority to AU58787/99A priority patent/AU756509B2/en
Priority to CN99812510A priority patent/CN1324233A/en
Priority to KR1020017005042A priority patent/KR20010075659A/en
Priority to ES99946377T priority patent/ES2272082T3/en
Priority to EP99946377A priority patent/EP1123088B1/en
Priority to PT99946377T priority patent/PT1123088E/en
Priority to OA1200100093A priority patent/OA11664A/en
Priority to EA200100298A priority patent/EA004068B1/en
Priority to PCT/IB1999/001619 priority patent/WO2000024383A1/en
Priority to NZ510275A priority patent/NZ510275A/en
Priority to PL99347476A priority patent/PL195789B1/en
Priority to SK519-2001A priority patent/SK286473B6/en
Priority to TR2001/01103T priority patent/TR200101103T2/en
Priority to APAP/P/2001/002125A priority patent/AP2001002125A0/en
Priority to DE69933383T priority patent/DE69933383T2/en
Priority to AT99946377T priority patent/ATE340562T1/en
Priority to IDW20010891A priority patent/ID28232A/en
Priority to IL141764A priority patent/IL141764A/en
Priority to DK99946377T priority patent/DK1123088T3/en
Priority to CA002348086A priority patent/CA2348086C/en
Priority to PA19998484301A priority patent/PA8484301A1/en
Priority to MA25820A priority patent/MA26700A1/en
Priority to MYPI99004535A priority patent/MY130727A/en
Priority to DZ990223A priority patent/DZ2923A1/en
Priority to ARP990105328 priority patent/AR019492A1/en
Priority to PE1999001062A priority patent/PE20001286A1/en
Priority to CO99066970A priority patent/CO5160262A1/en
Priority to US09/425,622 priority patent/US6964780B1/en
Priority to GT199900184A priority patent/GT199900184A/en
Priority to UY25765A priority patent/UY25765A1/en
Priority to IS5865A priority patent/IS5865A/en
Priority to CR6326A priority patent/CR6326A/en
Priority to HR20010285A priority patent/HRP20010285A2/en
Priority to NO20011933A priority patent/NO20011933L/en
Priority to BG105465A priority patent/BG65323B1/en
Priority to HK02103588.0A priority patent/HK1041818A1/en
Priority to CY20061101644T priority patent/CY1106239T1/en
Ceased legal-status Critical Current

Links

GBGB9826392.4A 1998-10-23 1998-11-27 Pharmaceutical formulations Ceased GB9826392D0 (en)

Priority Applications (46)

Application Number Priority Date Filing Date Title
GBGB9826392.4A GB9826392D0 (en) 1998-11-27 1998-11-27 Pharmaceutical formulations
UA2001042718A UA67802C2 (en) 1998-10-23 1999-04-10 CONTROLLED-RELEASE FORMULATIONS FOR ORAL ADMINISTRATION CONTAINING cGMP PDE-5 INHIBITOR (VARIANTS), METHOD FOR ITS PREPARATION AND METHOD FOR TREATING ERECTILE DYSFUNCTION
TW088116973A TW577756B (en) 1998-10-23 1999-10-01 Controlled-release pharmaceutical formulations
CA002348086A CA2348086C (en) 1998-10-23 1999-10-04 Controlled-release pharmaceutical formulations
APAP/P/2001/002125A AP2001002125A0 (en) 1998-10-23 1999-10-04 Controlled-rease pharmaceutical formulations.
AT99946377T ATE340562T1 (en) 1998-10-23 1999-10-04 DELAYED RELEASE PHARMACEUTICAL FORMULATIONS CONTAINING CGMP PDE-5 INHIBITOR
CZ20011427A CZ20011427A3 (en) 1998-10-23 1999-10-04 Pharmaceutical composition with controlled release and containing CGMP DPE-5 inhibitor
BR9914718-1A BR9914718A (en) 1998-10-23 1999-10-04 Controlled release pharmaceutical formulations comprising a pde-5 cgmp inhibitor
EEP200100235A EE200100235A (en) 1998-10-23 1999-10-04 Controlled release pharmaceutical formulations containing the cGMP PDE-5 inhibitor
MXPA01004011A MXPA01004011A (en) 1998-10-23 1999-10-04 Controlled-release pharmaceutical formulations containing a cgmp pde-5 inhibitor.
AU58787/99A AU756509B2 (en) 1998-10-23 1999-10-04 Controlled-release pharmaceutical formulations containing a cGMP PDE-5 inhibitor
CN99812510A CN1324233A (en) 1998-10-23 1999-10-04 Controlled-release pharmaceutical formulations contg. a CGMP PDE-5 inhibitor
KR1020017005042A KR20010075659A (en) 1998-10-23 1999-10-04 Controlled-Release Pharmaceutical Formulations Containing a CGMP PDE-5 Inhibitor
ES99946377T ES2272082T3 (en) 1998-10-23 1999-10-04 PHARMACEUTICAL FORMULATIONS OF CONTROLLED RELEASE CONTAINING A GMPC PDE-5 INHIBITOR.
DE69933383T DE69933383T2 (en) 1998-10-23 1999-10-04 Oral pharmaceutical formulations of cGMP PDE-5 controlled-release inhibitors
PT99946377T PT1123088E (en) 1998-10-23 1999-10-04 Sustained-release pharmaceutical formulations containing a cgmp pde-5 inhibitor
IDW20010891A ID28232A (en) 1998-10-23 1999-10-04 PHARMACEUTICAL FORMULATION WITH CONTROLLED CONTROL
EA200100298A EA004068B1 (en) 1998-10-23 1999-10-04 Controlled-release pharmaceutical formulations containing a cgmp pde-5 inhibitor
PCT/IB1999/001619 WO2000024383A1 (en) 1998-10-23 1999-10-04 Controlled-release pharmaceutical formulations containing a cgmp pde-5 inhibitor
NZ510275A NZ510275A (en) 1998-10-23 1999-10-04 Controlled-release pharmaceutical formulations containing a CGMP PDE-5 inhibitor
PL99347476A PL195789B1 (en) 1998-10-23 1999-10-04 Controlled-release pharmaceutical formulations containing a cgmp pde-5 inhibitor
SK519-2001A SK286473B6 (en) 1998-10-23 1999-10-04 Sustained-release or dual regimen release pharmaceutical composition containing cGMP PDE-5 inhibitor, method for the preparation thereof and use of cGMP PDE-5 inhibitor
TR2001/01103T TR200101103T2 (en) 1998-10-23 1999-10-04 Controlled release pharmaceutical formulations containing CGMP PDE-Inhibitor
HU0104318A HUP0104318A3 (en) 1998-10-23 1999-10-04 Controlled-release pharmaceutical formulations containing acgmp pde-5 inhibitor
EP99946377A EP1123088B1 (en) 1998-10-23 1999-10-04 Sustained-release pharmaceutical formulations containing a cgmp pde-5 inhibitor
JP2000577993A JP2002528408A (en) 1998-10-23 1999-10-04 Controlled release pharmaceutical formulation containing cGMPPDE-5 inhibitor
OA1200100093A OA11664A (en) 1998-10-23 1999-10-04 Controlled-release pharmaceutical formulations containing a cGMP PDE-5 inhibitor.
IL141764A IL141764A (en) 1998-10-23 1999-10-04 Controlled-release pharmaceutical formulations containing a cgmp pde-5 inhibitor
DK99946377T DK1123088T3 (en) 1998-10-23 1999-10-04 Sustained-release pharmaceutical formulations containing a cGMP PDE-5 inhibitor
PA19998484301A PA8484301A1 (en) 1998-10-23 1999-10-18 PHARMACEUTICAL FORMULATIONS OF CONTROLLED LIBERATION
MA25820A MA26700A1 (en) 1998-10-23 1999-10-20 PHARMACEUTICAL FORMULATIONS OF CONTROLLED RELEASE cGMP PDE-5 INHIBITORS AND PROCESS FOR THEIR PREPARATION.
DZ990223A DZ2923A1 (en) 1998-10-23 1999-10-20 Pharmaceutical formulations of pde-5 gmpc controlled release inhibitors, and process for their preparation.
MYPI99004535A MY130727A (en) 1998-10-23 1999-10-20 Controlled-release pharmaceutical formulations
ARP990105328 AR019492A1 (en) 1998-10-23 1999-10-21 PHARMACEUTICAL COMPOSITIONS OF CONTROLLED LIBERATION
PE1999001062A PE20001286A1 (en) 1998-10-23 1999-10-21 PHARMACEUTICAL FORMULATIONS OF CONTROLLED RELEASE OF INHIBITORS OF cGMP PDE-5
US09/425,622 US6964780B1 (en) 1998-10-23 1999-10-22 Controlled-release pharmaceutical formulations
GT199900184A GT199900184A (en) 1998-10-23 1999-10-22 PHARMACEUTICAL FORMULATIONS OF CONTROLLED LIBERATION.
CO99066970A CO5160262A1 (en) 1998-10-23 1999-10-22 PHARMACEUTICAL FORMULATIONS OF CONTROLLED LIBERATION
UY25765A UY25765A1 (en) 1998-10-23 1999-10-22 PHARMACEUTICAL FORMULATIONS OF CONTROLLED RELEASE
IS5865A IS5865A (en) 1998-10-23 2001-02-27 Controlled-release pharmaceutical compositions containing CGMP PDE-5 inhibitors
CR6326A CR6326A (en) 1998-10-23 2001-03-14 PHARMACEUTICAL FORMULATIONS OF CONTROLLED LIBERATION
NO20011933A NO20011933L (en) 1998-10-23 2001-04-19 Controlled-release pharmaceutical formulations containing a CGMP PDE-5 inhibitor
HR20010285A HRP20010285A2 (en) 1998-10-23 2001-04-19 Controlled-release pharmaceutical formulations containing a cgmp pde-5 inhibitor
BG105465A BG65323B1 (en) 1998-10-23 2001-04-24 Permanent-release pharmaceutical formulations containing a cgmp pde-5 inhibitor
HK02103588.0A HK1041818A1 (en) 1998-10-23 2002-05-13 Controlled-release pharmaceutical formulations containing a cgmp pde-5 inhibitor
CY20061101644T CY1106239T1 (en) 1998-10-23 2006-11-13 CONTROLLED-RELEASE PHARMACEUTICAL FORMULATIONS CONTAINING A cGMP PDE-5 INHIBITOR

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB9826392.4A GB9826392D0 (en) 1998-11-27 1998-11-27 Pharmaceutical formulations

Publications (1)

Publication Number Publication Date
GB9826392D0 true GB9826392D0 (en) 1999-01-27

Family

ID=10843445

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB9826392.4A Ceased GB9826392D0 (en) 1998-10-23 1998-11-27 Pharmaceutical formulations

Country Status (1)

Country Link
GB (1) GB9826392D0 (en)

Similar Documents

Publication Publication Date Title
SG79255A1 (en) Pharmaceutical formulations
GB9713149D0 (en) Pharmaceutical formulations
HK1041224A1 (en) New pharmaceutical formulation
CZ20011518A3 (en) Pharmaceutical preparation
HUP0103507A3 (en) Pharmaceutical compositions comprising 2-quinolones
GB9827996D0 (en) Pharmaceutical Compositions
GB9809213D0 (en) Pharmaceutical compositions
HK1040488A1 (en) Pharmaceutical formulations.
HK1045102A1 (en) Pharmaceutical formulations
GB9818927D0 (en) Pharmaceutical formulation
HK1030552A1 (en) Pharmaceutical compositions
GB9822333D0 (en) Pharmaceutical formulation
GB9817470D0 (en) Pharmaceutical formulation
GB9930578D0 (en) Pharmaceutical formulations
GB9906126D0 (en) Pharmaceutical formulations
GB9806487D0 (en) Pharmaceutical compositions
GB9802617D0 (en) Pharmaceutical formulation
GB9828205D0 (en) Pharmaceutical formulations
GB9817429D0 (en) Pharmaceutical formulations
GB9826392D0 (en) Pharmaceutical formulations
GB9807556D0 (en) Pharmaceutical formulations
GB9813452D0 (en) Pharmaceutical formulations
GB9816558D0 (en) Pharmaceutical formulations
GB9805931D0 (en) Pharmaceutical formulations
GB9825117D0 (en) Pharmaceutical formulations

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)